VAERS reports by lot

GSK Hepatitis A lot 9G523: VAERS reports

26 VAERS reports list lot 9G523 as a GSK Hepatitis A vaccine, received between 2025-09-02 and 2026-03-31. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
0%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)429%
Neurological321%
Cardiac / Cardiovascular214%
General / Systemic (non-local)214%
Injection-site / Local reaction214%
Gastrointestinal17%

Where reports came from

U.S. state of the reporter, where given (top 10).

StateReports
Maryland16
Missouri2
Massachusetts1
Michigan1
Kentucky1
Wisconsin1
Washington1
Minnesota1
Nebraska1
New Jersey1

Reports by month received

MonthReportsBar
2025-091
2025-101
2025-112
2025-1216
2026-012
2026-034

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): 95BJ9 · 95DB2 · 95EJ7 · 9K74F · 9P9B5 · 9PG49

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.